[Value of convalescent plasma in the therapy of COVID-19]. / Zum Stellenwert von Rekonvaleszentenplasma bei der Therapie von COVID-19.
Dtsch Med Wochenschr
; 148(7): 423-426, 2023 03.
Article
in German
| MEDLINE | ID: covidwho-2267038
ABSTRACT
Convalescent plasma was discussed as a therapeutic option early in the course of the COVID-19 pandemic. However, until the onset of the pandemic, only the results of mostly small single-arm studies in other infectious diseases were available, which did not prove efficacy. In the meantime, the results of more than 30 randomized trials of COVID-19 convalescent plasma (CCP) for treatment of COVID-19 are available 1. Despite the heterogeneity of the results, conclusions for an optimal use are possible.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
German
Journal:
Dtsch Med Wochenschr
Year:
2023
Document Type:
Article
Affiliation country:
A-2013-8775
Similar
MEDLINE
...
LILACS
LIS